Dec 6 (Reuters) - Herantis Pharma Plc HRTIS.HE :
* SAID ON TUESDAY COMPLETED DIRECTED SHARE ISSUE RAISING EUR
4.51
MLN
* EXPECTS TO ISSUE TOTAL OF 3,219,139 NEW SHARES IN DIRECTED
ISSUE, REPRESENTING ABOUT 19% OF ALL ISSUED SHARES PRIOR TO
DIRECTED ISSUE
* SUBSCRIPTION PRICE IS EUR 1.40 PER NEW SHARE,
CORRESPONDING TO
DISCOUNT OF ABOUT 16% TO CLOSING PRICE ON NASDAQ FIRST NORTH
GROWTH MARKET FINLAND ON 5 DEC 2023
Source text for Eikon: urn:newsml:reuters.com:*:nMFNnlP7k
Further company coverage: HRTIS.HE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))